Back to search

Article

Dasatinib‑Associated Chylothorax and Concurrent Bartonella henselae Infection in leukaemia Patients: A Systematic Review of Case Reports

2026-05-16

Abstract excerpt

Dasatinib is a second‑generation tyrosine kinase inhibitor (TKI) used in Philadelphia chromosome‑positive (Ph+) acute lymphoblastic leukaemia (ALL), and chylothorax is one of its rare but serious lymphatic complications. At the same time, patients with leukaemia are particularly vulnerable to atypical Bartonella henselae infection. This systematic review of multiple databases up to March 2026 identified 25 cases o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6e8f3ccf-69e4-5a9b-8629-9093dfa7c679
DOI
10.22541/authorea.15003412/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dasatinib‑Associated Chylothorax and Concurrent Bartonella henselae Infection in leukaemia Patients: A Systematic Review of Case ReportsDOI 10.22541/authorea.15003412/v1
Select a neighboring publication to make it the new centre.